CSU in Practice: Recognizing Uncontrolled Disease and What Comes Next

Patients may report improvement on antihistamines and still be living with uncontrolled chronic spontaneous urticaria. How do clinicians recognize that gap, particularly when there are no visible hives during the office visit? In this PANP360 webinar, Daniel Butler, MD, and David Seiter, FNP, DCNP, examine the often-underestimated burden of CSU, clinical considerations guiding treatment escalation, and the ways emerging therapeutic options inform shared decision-making. Along the way, they discuss translating clinical trial evidence into meaningful patient conversations, setting expectations, and navigating the practical challenges of delivering the care patients need.